Scaling cell therapy production workflows requires the establishment of closed, automated steps.
Evan Zynda
Advertisement
Evan Zynda, PhD, is senior scientist at Thermo Fisher Scientific.
Articles by Evan Zynda
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
